Cheng R - Search Results

1

Association of Body Mass Index With Clinicopathological Features of Papillary Thyroid Carcinoma: A Retrospective Study.

Dong Z, Liu W, Su F, Cheng R. Dong Z, et al. Among authors: cheng r. Endocr Pract. 2023 Feb;29(2):83-88. doi: 10.1016/j.eprac.2022.11.012. Epub 2022 Dec 5. Endocr Pract. 2023. PMID: 36481471

2

Neoadjuvant therapy with anlotinib in a locally advanced and pulmonary metastasis PTC patient harboring TERT promoter and BRAF^V600E mutations: a case report.

Su YJ, Cheng SH, Qian J, Zhang M, Liu W, Zhan XX, Wang ZQ, Liu HD, Zhong XW, Cheng RC. Su YJ, et al. Arch Endocrinol Metab. 2023 Jun 19;67(6):e000659. doi: 10.20945/2359-3997000000659. Arch Endocrinol Metab. 2023. PMID: 37364156 Free PMC article.

3

TPO as an indicator of lymph node metastasis and recurrence in papillary thyroid carcinoma.

Li X, Cheng R. Li X, et al. Among authors: cheng r. Sci Rep. 2023 Jul 5;13(1):10848. doi: 10.1038/s41598-023-37932-1. Sci Rep. 2023. PMID: 37407700 Free PMC article.

4

Trends of the prevalence rate of central lymph node metastasis and multifocality in patients with low-risk papillary thyroid carcinoma after delayed thyroid surgery.

Wang P, Dong Z, Zhao S, Su Y, Zhang J, Ma Y, Diao C, Qian J, Cheng R, Liu W. Wang P, et al. Among authors: cheng r. Front Endocrinol (Lausanne). 2024 Apr 4;15:1349272. doi: 10.3389/fendo.2024.1349272. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38638135 Free PMC article.

5

Expression of MUC1 and CD176 (Thomsen-Friedenreich antigen) in papillary thyroid carcinomas.

Zhan XX, Zhao B, Diao C, Cao Y, Cheng RC. Zhan XX, et al. Endocr Pathol. 2015 Mar;26(1):21-6. doi: 10.1007/s12022-015-9356-9. Endocr Pathol. 2015. PMID: 25614211

6

Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial.

Li D, Chi Y, Chen X, Ge M, Zhang Y, Guo Z, Wang J, Chen J, Zhang J, Cheng Y, Li Z, Liu H, Qin J, Zhu J, Cheng R, Xu Z, Zheng X, Tang P, Gao M. Li D, et al. Among authors: cheng y, cheng r. Clin Cancer Res. 2021 Jul 1;27(13):3567-3575. doi: 10.1158/1078-0432.CCR-20-2950. Epub 2021 Apr 8. Clin Cancer Res. 2021. PMID: 33832949 Clinical Trial.

7

Safety and effectiveness of carbon nanoparticles suspension-guided lymph node dissection during thyroidectomy in patients with thyroid papillary cancer: a prospective, multicenter, randomized, blank-controlled trial.

Zhao J, Wang J, Cheng R, Qin J, Ai Z, Sun H, Guo Z, Zhang X, Zheng X, Gao M. Zhao J, et al. Among authors: cheng r. Front Endocrinol (Lausanne). 2024 Jan 8;14:1251820. doi: 10.3389/fendo.2023.1251820. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38260138 Free PMC article. Clinical Trial.

8

[Thyroid lymphography:a new clinical approach for protecting parathyroid in surgery].

Bai YC, Cheng RC, Hong WJ, Ma YH, Qian J, Zhang JM. Bai YC, et al. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013 Sep;48(9):721-5. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013. PMID: 24330873 Chinese.

9

Exploration of the Potential Biomarkers of Papillary Thyroid Cancer (PTC) Based on RT² Profiler PCR Arrays and Bioinformatics Analysis.

Peng Y, Zhang HW, Cao WH, Mao Y, Cheng RC. Peng Y, et al. Cancer Manag Res. 2020 Sep 28;12:9235-9246. doi: 10.2147/CMAR.S266473. eCollection 2020. Cancer Manag Res. 2020. PMID: 33061614 Free PMC article.

10

A multicenter, prospective study to observe the initial management of patients with differentiated thyroid cancer in China (DTCC study).

Ming J, Zhu JQ, Zhang H, Sun H, Wang J, Cheng RC, Xie L, Li XR, Tian W, Huang T. Ming J, et al. BMC Endocr Disord. 2021 Oct 21;21(1):208. doi: 10.1186/s12902-021-00871-x. BMC Endocr Disord. 2021. PMID: 34670546 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,269 results

Search Page